Research Article

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations in the Presence of a Baseline Covariate

Table 4

Operating characteristics summarizing trial efficiency for with designs using covariate (WC), ignoring covariate (IC), and parallel trials (PT) considering discrete dose combinations.

Covariate DesignPS

Z = 0WC47.335.351.380.166.3
IC19.614.923.051.637.9
PT46.29.933.658.356.4

Z = 1WC55.325.772.585.571.6
IC47.617.959.579.662.7
PT81.616.271.488.088.9